We are testing a new beta website for gov.scot go to new site

Hepatitis C Action Plan for Scotland: Phase II: May 2008 - March 2011

Listen

References

  1. Chisholm M. Members' Debate on Hepatitis C, 30 th June. Edinburgh: Scottish Parliament; 2004.
  2. Hutchinson SJ, Roy KM, Wadd S, Bird SM, Taylor A, Anderson E, et al. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scott Med J 2006;51(2):8-15.
  3. Needs assessment of Hepatitis C testing, treatment, care and support services in Scotland: Overview report. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  4. Roy KM, Hutchinson SJ, Wadd S, Taylor A, Cameron SO, Burns S, et al. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them. Epidemiol Infect 2007;135(3):433-42.
  5. National Institute for Health and Clinical Excellence ( NICE). Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. London: NICE; 2006. Available from: http://www.nice.org.uk/nicemedia/pdf/TA106guidance.pdf
  6. Scottish Intercollegiate Guidelines Network ( SIGN). SIGN Guideline 92, Management of Hepatitis C: A national clinical guideline. Edinburgh: NHS Quality Improvement Scotland; 2006. Available from: http://sign.ac.uk/guidelines/published/numlist.html
  7. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Jr., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347(13):975-82.
  8. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358(9286):958-65.
  9. Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34(4 Pt 1):809-16.
  10. Scottish Executive Health Department ( SEHD). Hepatitis C Action Plan for Scotland. Phase 1: September 2006 - August 2008. Edinburgh: Scottish Executive; 2006. Available from: http://www.scotland.gov.uk/Publications/2006/09/15093626/0
  11. Health Protection Scotland. Scotland's Action Plan for Hepatitis C Phase 1 September 2006 - August 2008: First Year Progress Report. Glasgow: Health Protection Scotland; 2007. Available from: http://www.hepcscotland.co.uk/pdfs/scot-act-plan-hepc-p1-sep-2006-aug2008.pdf
  12. Needs assessment of Hepatitis C testing, treatment, care and support services in Scotland: a survey of laboratories undertaking Hepatitis C testing in Scotland. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  13. Health Protection Scotland. Surveillance of known hepatitis C antibody positive cases in Scotland: Results to 31 December 2006. HPS Weekly Report 2007;41(22);181-6. Available from: http://www.documents.hps.scot.nhs.uk/ewr/pdf2007/0722.pdf
  14. Hutchinson SJ, Bird SM, Goldberg DJ. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology 2005;42(3):711-23.
  15. Needs assessment of Hepatitis C testing, treatment, care and support services in Scotland: a survey of GP training practices. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  16. Needs assessment of C testing, treatment, care and support services in Scotland: a survey of Hepatitis C service providers. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  17. Hepatitis C Action Plan for Scotland: Testing, Treatment, Care and Support Working Group. Draft Guidelines for Hepatitis C Care Networks. Available from: http://www.hepcscotland.co.uk /pdfs/guidelines-for-hepatitis-c-care-networks.pdf
  18. Rowan ND, Hennessy P, Brown M. National mapping of Hepatitis C training provision in Scotland. Glasgow: UK Hepatitis C Resource Centre, NHS Education for Scotland; 2007. Available from: http://www.hepcscotland.co.uk
  19. Palmateer NE, Hutchinson SJ, McLeod A, Codere G, Goldberg DJ. Comparison of deaths related to Hepatitis C and AIDS in Scotland. J Viral Hepat 2007;14(12):870-4.
  20. Modelling the Impact of Antiviral Therapy on the Future Health and Economic Burden of Chronic Hepatitis in Scotland. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  21. Gore SM, Bird AG, Cameron SO, Hutchinson SJ, Burns SM, Goldberg DJ. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM 1999; 92(1):25-32.
  22. Needs assessment of Hepatitis C testing, treatment, care and support services in Scotland: analysis of qualitative data from focus groups and interviews with Hepatitis C service providers. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  23. Griesbach D, Abdulrahim D, Gordon D, Karin D. Needle Exchange Provision in Scotland: A Report of the National Needle Exchange Survey. Edinburgh: Scottish Executive Social Research Substance Misuse Research Programme; 2006. Available from: http://www.scotland.gov.uk/Publications/2006/06/16110001/0
  24. Anderson EA, Mandeville R Hutchinson SJ, Cameron SO, Mills PR, Fox R, Ahmed S, Taylor A, Spence E, Goldberg DJ. Evaluation of a general practice based Hepatitis C virus screening intervention. Scott Med J. In press 2008.
  25. Evaluation of a general-practice based screening intervention to identify former injecting drug users infected with Hepatitis C. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  26. Stout A. Hepatitis C Public Awareness-raising - International Review of Campaign Evaluations; 2007. Available from: http://www.hepcscotland.co.uk
  27. Hay G, Gannon M, McKeganey N, Hutchinson S, Goldberg D. Estimating the national and local prevalence of problem drug misuse in Scotland: Executive report. Edinburgh: Information Services Division Scotland; 2005. Available from: http://www.drugmisuse.isdscotland.org/publications/local/prevreport2004.pdf
  28. Information Services Division Scotland. Drug Misuse Statistics Scotland 2007. Edinburgh: Common Services Agency; 2007. Available from: http://www.drugmisuse.isdscotland.org/publications/abstracts/isdbull.htm
  29. Hutchinson SJ, Goldberg DJ, King M, Cameron SO, Shaw LE, Brown A, et al. Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis. Gut 2004;53(4):593-8.
  30. Hay JE. Viral Hepatitis in Pregnancy. Viral Hepatitis Reviews 2000;3:244-6.
  31. Scottish Executive Health Department Letter 2002 (75). Hepatitis C Infected Health Care Workers. Available from: http://www.sehd.scot.nhs.uk/mels/HDL2002_75.pdf
  32. The Civic Government (Scotland) Act 1982 (Licensing of Skin Piercing and Tattooing) Order 2006. Available from: http://www.opsi.gov.uk/legislation/scotland/ssi2006/20060043.htm
  33. The Civic Government (Scotland) Act 1982 (Licensing of Skin Piercing and Tattooing) Amendment Order 2006. Available from: http://www.opsi.gov.uk/legislation/scotland/ssi2006/ssi_20060604_en.pdf
  34. Scott J. Safety, Risks and Outcomes from the Use of Injecting Paraphernalia; 2008.
  35. Available from: http://www.scotland.gov.uk/Publications/2008/03/14133736/0
  36. Hutchinson SJ, Taylor A, Goldberg DJ, Gruer L. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses. Addiction 2000;95(6):931-40.
  37. Goldberg D, McIntyre PG, Smith R, Appleyard K, Dunlop J, Taylor A, et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. BJOG 2001;108(4):365-70.
  38. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of harm reduction interventions in preventing hepatitis C transmission among injecting drug users: A review of reviews. Glasgow: Health Protection Scotland; 2008. Available from: http://www.hepcscotland.co.uk (pending publication).
  39. Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect 2000;40(2):176-83.
  40. Goldberg D, Burns S, Taylor A, Cameron S, Hargreaves D, Hutchinson S. Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange. Scand J Infect Dis 2001;33(6):457-61.
  41. Hutchinson SJ, McIntyre PG, Molyneaux P, Cameron S, Burns S, Taylor A, et al. Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s. Epidemiol Infect 2002;128(3):473-7.
  42. Hutchinson SJ, Bird SM, Taylor A, Goldberg DJ. Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention. International Journal of Drug Policy 2006;17:211-221.
  43. Taylor A, Fleming A, Rutherford J, Goldberg D. Examining the Injecting Practices of Injecting Drug Users in Scotland; 2004. Scottish Executive Interventions Unit. Available from: http://www.drugmisuse.isdscotland.org/eiu/pubs/eiu_060.htm .
  44. Scottish Prison Service. 10 th Prisoner Survey 2007. Edinburgh: Scottish Prison Service. Available from: http://www.sps.gov.uk/MultimediaGallery/b662de7f-c9b3-41c6-a14b-e793340c27f0.pdf.
  45. Taylor A, Goldberg D. Outbreak of HIV infection in a Scottish prison: why did it happen? Canadian HIV/ AIDS Policy & Law Newsletter 1996;2:13-14.
  46. Champion JK, Taylor A, Hutchinson S, Cameron S, McMenamin J, Mitchell A, et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol 2004;159(5):514-9.
  47. Dowds J, Campbell M, and Niamh Fitzgerald. A Review of Current Teaching on Hepatitis C in Scottish Educational Establishments. Glasgow: Create Consultancy; 2007. Available from: http://www.hepcscotland.co.uk.
  48. Chatzipantazi P, Roy KM, Cameron SO, Goldberg D, Welbury R, Bagg J. The feasibility and acceptability of collecting oral fluid from healthy children for anti- HCV testing. Arch Dis Child 2004;89(2):185-7.
  49. General Register Office Scotland. 2001 Census results. Available from: http://www.gro-scotland.gov.uk/grosweb/grosweb.nsf/pages/censushm
  50. Anderson E, Hutchinson S, Shaw L, Codere G, McLeod A. Excess risk of known HCV infection among Glasgow's older Pakistani population [abstract]. Proceedings of the Northern European Conference on Travel Medicine; 2006 Jun 7-10; Edinburgh, UK. Edinburgh: NECTM; 2006.
  51. Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004;14(9):534-6.
  52. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002;52(9):398-402.
  53. Parker SP, Khan HI, Cubitt WD. Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. J Clin Microbiol 1999;37(6):2061-3.
  54. Rendall M, Salt J. Chapter 8: The foreign-born population. In: Focus on People and Migration: 2005. London: Office for National Statistics; 2005. p. 131-152. Available from: http://www.statistics.gov.uk/focuson/migration/